L3VLUP
ProSign in

LEGN in the 13F filings

Legend Biotech Corp · CUSIP 52490G102

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Mar 2025
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 2 May 2025
Managers listing it
8
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q4 2024 and Q1 2025; 7 listed it in both
Shares listed
26,925,158
combined, among listed positions
Reported value
$916m
combined, at the quarter end

Among the 95 comparable managers: 4 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing LEGN in Q1 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

8 of 8 holders

ActionFiling
Fidelity (FMR LLC)13,204,213$448munder 0.1%Trimmedn.a.5 Nov 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc6,729,779$228munder 0.1%Trimmed-78,30214 May 2025 (the filing on sec.gov)
MFS Investment Management2,270,264$77munder 0.1%Added+6,7082 May 2025 (the filing on sec.gov)
Janus Henderson Group Ltd2,057,804$72munder 0.1%Trimmed-98,94515 May 2025 (the filing on sec.gov)
Artisan Partners LP1,131,768$38m0.06%Trimmed-373,79414 May 2025 (the filing on sec.gov)
Two Sigma Investments LP801,781$27m0.06%Added+159,32915 May 2025 (the filing on sec.gov)
Two Sigma Advisers LP504,100$17munder 0.1%Added+176,70015 May 2025 (the filing on sec.gov)
Bridgewater Associates LP225,449$7.6munder 0.1%Added+63,72614 May 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2024 to Q1 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
9 in Q3 2024 to 5 in Q2 2026

Tracked managers listing it, at least.

051015202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
LEGN by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20204$159mn.a.n.a.
Q3 20202$116mn.a.n.a.
Q4 20203$123mn.a.n.a.
Q1 20214$170mn.a.n.a.
Q2 20214$178mn.a.n.a.
Q3 20215$387mn.a.n.a.
Q4 20216$401mn.a.n.a.
Q1 20227$338mn.a.n.a.
Q2 20229$993mn.a.n.a.
Q3 20228$847mn.a.n.a.
Q4 20229$1.1bnn.a.n.a.
Q1 202310$1.2bnn.a.n.a.
Q2 202311$2.5bnn.a.n.a.
Q3 202312$2.4bnn.a.n.a.
Q4 202311$2.1bn65
Q1 202410$2.1bn54
Q2 20248$1.6bn54
Q3 20249$1.8bn72
Q4 202410$523m64
Q1 20258$916m44
Q2 20256$1.1bn60
Q3 20255$1.1bn50
Q4 20256$679m1411
Q1 20264$155m159
Q2 20265$1.0bn913

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

LEGN and LLY →LEGN and JNJ →LEGN and VRTX →Choose a stock to compare with LEGN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own LEGN, latest filings →Back to the 13F Explorer →